These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24179107)

  • 21. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.
    Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
    Am J Kidney Dis; 2005 Sep; 46(3):512-9. PubMed ID: 16129214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heritability and clinical determinants of serum indoxyl sulfate and p-cresyl sulfate, candidate biomarkers of the human microbiome enterotype.
    Viaene L; Thijs L; Jin Y; Liu Y; Gu Y; Meijers B; Claes K; Staessen J; Evenepoel P
    PLoS One; 2014; 9(5):e79682. PubMed ID: 24850265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children.
    Holle J; Kirchner M; Okun J; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Duzova A; Ranchin B; Shroff R; Candan C; Oh J; Klaus G; Lugani F; Gimpel C; Büscher R; Yilmaz A; Baskin E; Erdogan H; Zaloszyc A; Özcelik G; Drozdz D; Jankauskiene A; Nobili F; Melk A; Querfeld U; Schaefer F;
    PLoS One; 2020; 15(10):e0240446. PubMed ID: 33108385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uremic toxin development in living kidney donors: a longitudinal study.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Haluska BA; Hawley CM; Dimeski G; McWhinney BC; Ungerer JP; Kaisar OM; Isbel NM
    Transplantation; 2014 Mar; 97(5):548-54. PubMed ID: 24162249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.
    Veldeman L; Vanmassenhove J; Van Biesen W; Massy ZA; Liabeuf S; Glorieux G; Vanholder R
    Int Urol Nephrol; 2019 Feb; 51(2):293-302. PubMed ID: 30604232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion.
    Rivara MB; Zelnick LR; Hoofnagle AN; Newitt R; Tracy RP; Kratz M; Weigle DS; Kestenbaum BR
    Clin Chem; 2017 Apr; 63(4):915-923. PubMed ID: 28188231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
    Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
    Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time.
    Krieter DH; Kerwagen S; Rüth M; Lemke HD; Wanner C
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30654454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.
    Meijers BK; De Preter V; Verbeke K; Vanrenterghem Y; Evenepoel P
    Nephrol Dial Transplant; 2010 Jan; 25(1):219-24. PubMed ID: 19692415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).
    Rocchetti MT; Cosola C; di Bari I; Magnani S; Galleggiante V; Scandiffio L; Dalfino G; Netti GS; Atti M; Corciulo R; Gesualdo L
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.
    Vanholder R; Schepers E; Pletinck A; Nagler EV; Glorieux G
    J Am Soc Nephrol; 2014 Sep; 25(9):1897-907. PubMed ID: 24812165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of residual function to removal of protein-bound solutes in hemodialysis.
    Marquez IO; Tambra S; Luo FY; Li Y; Plummer NS; Hostetter TH; Meyer TW
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):290-6. PubMed ID: 21030575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
    Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
    Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bowel Habits and the Association With Uremic Toxins in Non-Dialysis-Dependent Chronic Kidney Disease Patients.
    Ramos CI; Armani RG; Canziani ME; Ribeiro Dolenga CJ; Nakao LS; Campbell KL; Cuppari L
    J Ren Nutr; 2020 Jan; 30(1):31-35. PubMed ID: 30956092
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Chen Z; Xu J; Xing X; Xue C; Luo X; Gao S; Mao Z
    Ren Fail; 2022 Dec; 44(1):1791-1800. PubMed ID: 36278836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.
    Bao M; Zhang P; Guo S; Zou J; Ji J; Ding X; Yu X
    Front Cell Infect Microbiol; 2022; 12():639624. PubMed ID: 36237423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.
    Panichi V; Rocchetti MT; Scatena A; Rosati A; Migliori M; Pizzarelli F; Gesualdo L;
    J Nephrol; 2017 Aug; 30(4):583-591. PubMed ID: 28337716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease.
    Wang CP; Lu YC; Tsai IT; Tang WH; Hsu CC; Hung WC; Yu TH; Chen SC; Chung FM; Lee YJ; Houng JY
    Dermatology; 2016; 232(3):363-70. PubMed ID: 27161100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.
    Holle J; Querfeld U; Kirchner M; Anninos A; Okun J; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Duzova A; Anarat A; Shroff R; Bilginer Y; Caliskan S; Candan C; Harambat J; Özcakar ZB; Soylemezoglu O; Tschumi S; Habbig S; Yilmaz E; Balat A; Zurowska A; Cakar N; Kranz B; Ertan P; Melk A; Azukaitis K; Schaefer F
    Pediatr Nephrol; 2019 Dec; 34(12):2571-2582. PubMed ID: 31428929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.